Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Viñolas

Showing results (31-40 of 48) with videos related to

Pageof 5
Sort By:
Anticancer Research|May 16, 1998
Tumor markers in response monitoring and prognosis of non-small cell lung cancer: preliminary reportN Viñolas, R Molina, M C Galán, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
Chronic oral etoposide in non-small cell lung carcinomaJ Estapé, H Palombo, J Sánchez-Lloret, et al.
American Journal of Hematology|March 1, 1988
Combined assay of adenosine deaminase, purine nucleoside phosphorylase, and lactate dehydrogenase in the early clinical evaluation of B-chronic lymphocytic leukemiaJ L Vives Corrons, C Rozman, M A Pujades, et al.
Journal of the National Cancer Institute|March 5, 1997
Serum anti-p53 antibodies and prognosis of patients with small-cell lung cancerM R Rosenfeld, N Malats, L Schramm, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|November 27, 2013
Lung cancer in women: an overview with special focus on Spanish womenJ Remon, E Molina-Montes, M Majem, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|December 5, 2003
Tumor markers (CEA, CA 125, CYFRA 21-1, SCC and NSE) in patients with non-small cell lung cancer as an aid in histological diagnosis and prognosis. Comparison with the main clinical and pathological prognostic factorsR Molina, X Filella, J M Augé, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|January 30, 2013
Cisplatin plus oral vinorelbine as first-line treatment for advanced non-small-cell lung cancer: a prospective study confirming that the day-8 hemogram is unnecessaryM Provencio, A Sánchez, A Artal, et al.
European Journal of Haematology|November 1, 1996
CHOP vs. ProMACE-CytaBOM in the treatment of aggressive non-Hodgkin's lymphomas: long-term results of a multicenter randomized trial.(PETHEMA: Spanish Cooperative Group for the Study of Hematological Malignancies Treatment, Spanish Society of Hematology)E Montserrat, J García-Conde, N Viñolas, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 2, 2021
Cell-free DNA concentration and fragment size fraction correlate with FDG PET/CT-derived parameters in NSCLC patientsJ M González de Aledo-Castillo, S Casanueva-Eliceiry, A Soler-Perromat, et al.
Lung Cancer (Amsterdam, Netherlands)|June 26, 2019
Trained dogs can identify malignant solitary pulmonary nodules in exhaled gasA Guirao, L Molins, I Ramón, et al.
Pageof 5

Showing results (31-40 of 48) with videos related to

Sort By:
Pageof 5
Anticancer Research|May 16, 1998
Tumor markers in response monitoring and prognosis of non-small cell lung cancer: preliminary reportN Viñolas, R Molina, M C Galán, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
Chronic oral etoposide in non-small cell lung carcinomaJ Estapé, H Palombo, J Sánchez-Lloret, et al.
American Journal of Hematology|March 1, 1988
Combined assay of adenosine deaminase, purine nucleoside phosphorylase, and lactate dehydrogenase in the early clinical evaluation of B-chronic lymphocytic leukemiaJ L Vives Corrons, C Rozman, M A Pujades, et al.
Journal of the National Cancer Institute|March 5, 1997
Serum anti-p53 antibodies and prognosis of patients with small-cell lung cancerM R Rosenfeld, N Malats, L Schramm, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|November 27, 2013
Lung cancer in women: an overview with special focus on Spanish womenJ Remon, E Molina-Montes, M Majem, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|December 5, 2003
Tumor markers (CEA, CA 125, CYFRA 21-1, SCC and NSE) in patients with non-small cell lung cancer as an aid in histological diagnosis and prognosis. Comparison with the main clinical and pathological prognostic factorsR Molina, X Filella, J M Augé, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|January 30, 2013
Cisplatin plus oral vinorelbine as first-line treatment for advanced non-small-cell lung cancer: a prospective study confirming that the day-8 hemogram is unnecessaryM Provencio, A Sánchez, A Artal, et al.
European Journal of Haematology|November 1, 1996
CHOP vs. ProMACE-CytaBOM in the treatment of aggressive non-Hodgkin's lymphomas: long-term results of a multicenter randomized trial.(PETHEMA: Spanish Cooperative Group for the Study of Hematological Malignancies Treatment, Spanish Society of Hematology)E Montserrat, J García-Conde, N Viñolas, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 2, 2021
Cell-free DNA concentration and fragment size fraction correlate with FDG PET/CT-derived parameters in NSCLC patientsJ M González de Aledo-Castillo, S Casanueva-Eliceiry, A Soler-Perromat, et al.
Lung Cancer (Amsterdam, Netherlands)|June 26, 2019
Trained dogs can identify malignant solitary pulmonary nodules in exhaled gasA Guirao, L Molins, I Ramón, et al.
Pageof 5